Disease-Modifying MS Therapies Market Growth, Company Revenue Share, Key Drivers & Trend Analysis By FMI
Future Market Insights (FMI) today released a comprehensive analysis of the global disease-modifying MS therapies market, projecting steady growth over the next decade. The market, valued at USD 31,915.8 million in 2026, is anticipated to reach USD 63,372.5 million by 2036, registering a compound annual growth rate (CAGR) of 7.1%. This expansion reflects increasing emphasis on early...
0 التعليقات 0 المشاركات 56 مشاهدة 0 معاينة
Girbir https://girbir.com